🇺🇸 FDA
Patent

US 10688102

Combination treatment for migraine and other pain

granted A61KA61K31/4184A61K31/4196

Quick answer

US patent 10688102 (Combination treatment for migraine and other pain) held by AXSOME THERAPEUTICS, INC. expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/4184, A61K31/4196, A61K31/50, A61K31/5415